Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922335 · ClinicalTrials.gov registry record · NA
Multisystemic Therapy-Emerging Adults Trial
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT02922335 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 193 participants.
The verdict
NCT02922335, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
This study's purpose is to test the effectiveness of a promising intervention for emerging adults (EAs) with mental illness (MI) and serious antisocial behavior in achieving the ultimate outcome of reduced antisocial behavior, and proximal intermediate outcomes. Multisystemic Therapy-Emerging Adults (MST-EA) is an adaptation of MST, a well-established, effective intervention for antisocial behavior in adolescents.
Interventions
- BEHAVIORAL Enhanced Treatment as Usual
- BEHAVIORAL Multisystemic Therapy for Emerging Adults
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02922335
The ClinicalTrials.gov registry entry for NCT02922335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Treatment as Usual is the first listed.
NCT02922335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02922335 about?
NCT02922335 is a clinical study titled "Multisystemic Therapy-Emerging Adults Trial". This study's purpose is to test the effectiveness of a promising intervention for emerging adults (EAs) with mental illness (MI) and serious antisocial behavior in achieving the ultimate outcome of reduced antisocial behavior, and proximal intermediate outcomes. Multisystemic Therapy-Emerging Adults...
What is the current status of trial NCT02922335?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2016-09-01. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT02922335?
The interventions under investigation include: Enhanced Treatment as Usual (BEHAVIORAL), Multisystemic Therapy for Emerging Adults (BEHAVIORAL).
Who is sponsoring clinical trial NCT02922335?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.